Author

Lizzi Neylon

Institutions: Barrow Neurological Institute, Target ALS

Observed institutions: Barrow Neurological Institute, Target ALS

OpenAlex ID: A5139150423

The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosis

2026 · Daisuke Yasui, Daniel Weatherill, et al. · medRxiv

Works count: 1

Citation count:

H-index:

I10-index: